17
Participants
Start Date
July 31, 2012
Primary Completion Date
April 30, 2016
Study Completion Date
April 30, 2016
Lamivudine
"Lamivudine 100 mg p.o. q.d.~This process will be stratified by prolonged PT, \< 4 sec / 4-6 sec / \> 6 sec. Both lamivudine and entecavir will be taken once daily and the first dose of observational drug should be administered on Day 1. The observational period of individual subject will be 12 weeks; however, both treatments could be continued after the end of study based on physician's clinical judgment."
Entecavir
"•Entecavir 0.5 mg p.o. q.d~This process will be stratified by prolonged PT, \< 4 sec / 4-6 sec / \> 6 sec. Both lamivudine and entecavir will be taken once daily and the first dose of observational drug should be administered on Day 1. The observational period of individual subject will be 12 weeks; however, both treatments could be continued after the end of study based on physician's clinical judgment."
Taichung Veterans General Hospital, Taichung
Tung's Taiching MetroHarbor Hospital, Taichung
Changhua Christian Hospital, Changhua
National Taiwan University Hospital Yu-Lin Branch, YuLin
Chung Shan Medical University Hospital, Taichung
China Medical University Hospital, Taichung
ChengChing Hospital, Taichung
Chia-Yi Christian, Chiayi City
Collaborators (1)
GlaxoSmithKline
INDUSTRY
Taichung Veterans General Hospital
OTHER